Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Concetta Fargnoli

Showing results (221-230 of 284) with videos related to

Pageof 29
Sort By:
Familial Cancer|July 3, 2021
Novel MAPK/AKT-impairing germline NRAS variant identified in a melanoma-prone familyKevin M Brown, Mai Xu, Michael Sargen, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 15, 2021
A multicenter study of skin toxicity management in patients with left-sided, RAS/BRAF wild-type metastatic colorectal cancer treated with first-line anti-EGFR-based doublet regimen: is there room for improvement?Paolo Antonetti, Maria Concetta Fargnoli, Giampiero Porzio, et al.
Dermatology and Therapy|July 1, 2022
Update on the Management of Pediatric Psoriasis: An Italian ConsensusKetty Peris, Anna Belloni Fortina, Luca Bianchi, et al.
International Journal of Cancer|June 12, 2014
MC1R variants increased the risk of sporadic cutaneous melanoma in darker-pigmented Caucasians: a pooled-analysis from the M-SKIP projectElena Pasquali, José C García-Borrón, Maria Concetta Fargnoli, et al.
Dermatology and Therapy|September 24, 2024
Secukinumab in the Treatment of Psoriasis: A Narrative Review on Early Treatment and Real-World EvidencePiergiorgio Malagoli, Paolo Dapavo, Paolo Amerio, et al.
Dermatology and Therapy|February 16, 2026
Real-World Efficacy of IL-23 Inhibitors in Psoriasis Affecting High-Impact Areas: Indirect Comparison of Tildrakizumab 200 mg, Risankizumab, and Guselkumab-IL PSO (Italian Landscape Psoriasis)Emanuele Trovato, Alessandra Cartocci, Francesca Gaiani, et al.
Human Molecular Genetics|July 31, 2018
Combining common genetic variants and non-genetic risk factors to predict risk of cutaneous melanomaFangyi Gu, Ting-Huei Chen, Ruth M Pfeiffer, et al.
European Journal of Cancer (Oxford, England : 1990)|August 21, 2023
European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma-update 2023Ketty Peris, Maria Concetta Fargnoli, Roland Kaufmann, et al.
Journal of Clinical Medicine|May 28, 2022
Sharing Patient and Clinician Experiences of Moderate-to-Severe Psoriasis: A Nationwide Italian Survey and Expert Opinion to Explore Barriers Impacting upon Patient WellbeingFrancesca Prignano, Alexandra M G Brunasso, Gabriella Fabbrocini, et al.
Photodermatology, Photoimmunology & Photomedicine|January 18, 2021
Italian expert-based recommendations on the use of photo(chemo)therapy in the management of mycosis fungoides: Results of an e-Delphi consensusVieri Grandi, Antonello Baldo, Emilio Berti, et al.
Pageof 29

Showing results (221-230 of 284) with videos related to

Sort By:
Pageof 29
Familial Cancer|July 3, 2021
Novel MAPK/AKT-impairing germline NRAS variant identified in a melanoma-prone familyKevin M Brown, Mai Xu, Michael Sargen, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 15, 2021
A multicenter study of skin toxicity management in patients with left-sided, RAS/BRAF wild-type metastatic colorectal cancer treated with first-line anti-EGFR-based doublet regimen: is there room for improvement?Paolo Antonetti, Maria Concetta Fargnoli, Giampiero Porzio, et al.
Dermatology and Therapy|July 1, 2022
Update on the Management of Pediatric Psoriasis: An Italian ConsensusKetty Peris, Anna Belloni Fortina, Luca Bianchi, et al.
International Journal of Cancer|June 12, 2014
MC1R variants increased the risk of sporadic cutaneous melanoma in darker-pigmented Caucasians: a pooled-analysis from the M-SKIP projectElena Pasquali, José C García-Borrón, Maria Concetta Fargnoli, et al.
Dermatology and Therapy|September 24, 2024
Secukinumab in the Treatment of Psoriasis: A Narrative Review on Early Treatment and Real-World EvidencePiergiorgio Malagoli, Paolo Dapavo, Paolo Amerio, et al.
Dermatology and Therapy|February 16, 2026
Real-World Efficacy of IL-23 Inhibitors in Psoriasis Affecting High-Impact Areas: Indirect Comparison of Tildrakizumab 200 mg, Risankizumab, and Guselkumab-IL PSO (Italian Landscape Psoriasis)Emanuele Trovato, Alessandra Cartocci, Francesca Gaiani, et al.
Human Molecular Genetics|July 31, 2018
Combining common genetic variants and non-genetic risk factors to predict risk of cutaneous melanomaFangyi Gu, Ting-Huei Chen, Ruth M Pfeiffer, et al.
European Journal of Cancer (Oxford, England : 1990)|August 21, 2023
European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma-update 2023Ketty Peris, Maria Concetta Fargnoli, Roland Kaufmann, et al.
Journal of Clinical Medicine|May 28, 2022
Sharing Patient and Clinician Experiences of Moderate-to-Severe Psoriasis: A Nationwide Italian Survey and Expert Opinion to Explore Barriers Impacting upon Patient WellbeingFrancesca Prignano, Alexandra M G Brunasso, Gabriella Fabbrocini, et al.
Photodermatology, Photoimmunology & Photomedicine|January 18, 2021
Italian expert-based recommendations on the use of photo(chemo)therapy in the management of mycosis fungoides: Results of an e-Delphi consensusVieri Grandi, Antonello Baldo, Emilio Berti, et al.
Pageof 29